Similar articles

• Pitfalls in the assessment of the specific binding of(-)[3H]-dihydroalprenolol to beta-adrenoceptors [proceedings].

  Nahorski SR, Richardson A. Nahorski SR, et al. Br J Pharmacol. 1979 Jul;66(3):469P-470P. Br J Pharmacol. 1979. PMID: 230879 Free PMC article. No abstract available.
• Irreversible blockade of beta adrenoreceptors and their recovery in the rat heart and lung in vivo.

  Baker SP, Pitha J. Baker SP, et al. J Pharmacol Exp Ther. 1982 Feb;220(2):247-51. J Pharmacol Exp Ther. 1982. PMID: 6120224
• Binding of (3H)dihydroalprenolol to beta adrenoceptors of cells isolated from adult rat heart.

  Moustafa E, Giachetti A, Downey HF, Bashour FA. Moustafa E, et al. Naunyn Schmiedebergs Arch Pharmacol. 1978 May;303(1):107-9. doi: 10.1007/BF00496192. Naunyn Schmiedebergs Arch Pharmacol. 1978. PMID: 209345
• [3H]dihydroalprenolol binding in the rat brainstem.

  Stone EA, U'Prichard DC. Stone EA, et al. Eur J Pharmacol. 1981 Oct 22;75(2-3):159-61. doi: 10.1016/0014-2999(81)90078-9. Eur J Pharmacol. 1981. PMID: 6119217
• Identity of [3H]-dihydroalprenolol binding sites and beta-adrenergic receptors coupled with adenylate cyclase in the central nervous system: pharmacological properties, distribution and adaptive responsiveness.

  Dolphin A, Adrien J, Hamon M, Bockaert J. Dolphin A, et al. Mol Pharmacol. 1979 Jan;15(1):1-15. Mol Pharmacol. 1979. PMID: 218089 No abstract available.